Neural Regeneration Research,
Год журнала:
2022,
Номер
18(4), С. 708 - 708
Опубликована: Сен. 21, 2022
Alzheimer's
disease
is
characterized
by
sustained
neuroinflammation
leading
to
memory
loss
and
cognitive
decline.
The
past
decade
has
witnessed
tremendous
efforts
in
research;
however,
no
effective
treatment
available
prevent
progression.
An
increasing
body
of
evidence
suggests
that
plays
an
important
role
pathogenesis,
alongside
the
classical
pathological
hallmarks
such
as
misfolded
aggregated
proteins
(e.g.,
amyloid-beta
tau).
Firstly,
this
review
summarized
clinical
characteristics
disease.
Secondly,
we
outlined
key
aspects
glial
cell-associated
inflammation
pathogenesis
provided
latest
on
roles
microglia
astrocytes
pathology.
Then,
revealed
double-edged
nature
inflammatory
cytokines
inflammasomes
In
addition,
potential
therapeutic
innate
immunity
for
were
also
discussed
through
these
mechanisms.
final
section,
remaining
problems
according
current
research
status
discussed.
Frontiers in Cellular Neuroscience,
Год журнала:
2020,
Номер
14
Опубликована: Авг. 6, 2020
Inflammatory
processes
and
microglia
activation
accompanies
most
of
the
pathophysiological
diseases
in
central
nervous
system.
It
is
proven
that
glial
pathology
precedes
even
drives
development
multiple
neurodegenerative
conditions.
A
growing
number
studies
point
out
importance
brain
as
well
physiological
functioning.
Those
resident
immune
cells
are
divergent
from
peripherally
infiltrated
macrophages,
but
their
precise
situ
discrimination
surprisingly
difficult.
Microglia
heterogeneity
visible
especially
morphology,
cell
density
particular
structures,
also
expression
cellular
markers.
This
often
determines
role
physiology
or
The
species
differences
between
rodent
human
markers
add
complexity
to
whole
picture.
Furthermore,
due
activation,
shows
a
broad
spectrum
phenotypes
ranging
pro-inflammatory,
potentially
cytotoxic
M1,
anti-inflammatory,
scavenging
regenerative
M2.
distinction
specific
nowadays
essential
study
microglial
functions
tissue
state
such
quickly
changing
environment.
Due
overwhelming
data
on
sets
available
for
studies,
choice
appropriate
scientific
challenge.
review
gathers,
classifies
describes
known
recently
discovered
protein
expressed
by
different
phenotypes.
Presented
include
qualitative
semi-quantitative,
general
specific,
surface
intracellular
proteins
secreted
molecules.
Information
provided
here
creates
comprehensive
practical
guide
trough
current
knowledge
will
allow
choose
proper,
more
detailed
neuroinflammatory
mechanisms
various,
physiological,
pathological,
Both,
basic
research
clinical
medicine,
need
clearly
described
validated
molecular
phenotype,
diagnostics,
treatment
prevention
engaging
glia
activation.
Molecular Psychiatry,
Год журнала:
2019,
Номер
25(2), С. 351 - 367
Опубликована: Ноя. 26, 2019
Abstract
Microglia
have
been
recently
shown
to
manifest
a
very
interesting
phenotypical
heterogeneity
across
different
regions
in
the
mammalian
central
nervous
system
(CNS).
However,
underlying
mechanism
and
functional
meaning
of
this
phenomenon
are
currently
unclear.
Baseline
diversities
adult
microglia
their
cell
number,
cellular
subcellular
structures,
molecular
signature
as
well
relevant
functions
discovered.
But
recent
transcriptomic
studies
using
bulk
RNAseq
single-cell
produced
conflicting
results
on
region-specific
signatures
microglia.
It
is
highly
speculative
whether
such
spatial
contributes
varying
sensitivities
individual
same
physiological
pathological
signals
CNS
regions,
hence
underlie
relevance
for
disease
development.
This
review
aims
thoroughly
summarize
up-to-date
knowledge
specific
topic
provide
some
insights
potential
mechanisms,
starting
from
microgliogenesis.
Understanding
regional
context
diverse
neighboring
neurons
other
glia
may
an
important
clue
future
development
innovative
therapies
neuropsychiatric
disorders.
Cells,
Год журнала:
2020,
Номер
9(7), С. 1717 - 1717
Опубликована: Июль 17, 2020
The
pro-inflammatory
immune
response
driven
by
microglia
is
a
key
contributor
to
the
pathogenesis
of
several
neurodegenerative
diseases.
Though
research
spans
over
century,
last
two
decades
have
increased
our
understanding
exponentially.
Here,
we
discuss
phenotypic
transformation
from
homeostatic
towards
reactive
microglia,
initiated
specific
ligand
binding
pattern
recognition
receptors
including
toll-like
receptor-4
(TLR4)
or
triggering
expressed
on
myeloid
cells-2
(TREM2),
as
well
signaling
pathways
triggered
such
caspase-mediated
response.
Additionally,
new
disciplines
epigenetics
and
immunometabolism
provided
us
with
more
holistic
view
how
changes
in
DNA
methylation,
microRNAs,
metabolome
may
influence
This
review
aimed
current
knowledge
different
angles,
recent
highlights
role
exosomes
spreading
neuroinflammation
emerging
techniques
positron
emission
tomography
(PET)
scanning
use
human
generated
induced
pluripotent
stem
cells
(iPSCs).
Finally,
also
thoughts
impact
Frontiers in Immunology,
Год журнала:
2020,
Номер
11
Опубликована: Март 31, 2020
Neuroinflammation
commences
decades
before
Alzheimer's
disease
(AD)
clinical
onset
and
represents
one
of
the
earliest
pathomechanistic
alterations
throughout
AD
its
continuum.
Large-scale
genome-wide
association
studies
point
out
several
genetic
variants
-
TREM2,
CD33,
PILRA,
CR1,
MS4A,
CLU,
ABCA7,
EPHA1,
HLA-DRB5-HLA-DRB1
potentially
linked
to
neuroinflammation.
Most
these
genes
are
involved
in
proinflammatory
intracellular
signaling,
cytokines/interleukins
cell
turn-over,
synaptic
activity,
lipid
metabolism,
vesicle
trafficking.
Proteomic
indicate
that
a
plethora
interconnected
aberrant
molecular
pathways,
set
off
perpetuated
by
TNF-α,
TGF-β,
IL-1β,
receptor
protein
Microglia
astrocytes
key
cellular
drivers
regulators
Under
physiological
conditions,
they
important
for
neurotransmission
homeostasis.
In
AD,
there
is
turning
pathophysiological
evolution
where
glial
cells
sustain
an
overexpressed
inflammatory
response
synergizes
with
amyloid-β
tau
accumulation,
drives
synaptotoxicity
neurodegeneration
self-reinforcing
manner.
Despite
strong
therapeutic
rationale,
previous
trials
investigating
compounds
anti-inflammatory
properties,
including
non-steroidal
drugs
(NSAIDs)
did
not
achieve
primary
efficacy
endpoints.
It
conceivable
study
design
issues,
lack
diagnostic
accuracy
biomarkers
target
population
identification
proof-of-mechanism
may
partially
explain
negative
outcomes.
However,
recent
meta-analysis
indicates
potential
biological
effect
NSAIDs.
this
regard,
candidate
fluid
neuroinflammation
under
analytical/clinical
validation,
i.e.
MCP-1,
IL-6,
TNF-α
complexes,
YKL-40.
PET
radio-ligands
investigated
accomplish
in-vivo
longitudinal
regional
exploration
Biomarkers
tracking
different
pathways
(body
matrixes)
along
brain
neuroinflammatory
endophenotypes
(neuroimaging
markers),
can
untangle
temporal-spatial
dynamics
between
other
mechanisms.
Robust
biomarker-drug
co-development
pipelines
expected
enrich
large-scale
testing
new-generation
active,
directly
or
indirectly,
on
targets
displaying
putative
disease-modifying
effects:
novel
NSAIDs,
AL002
(anti-TREM2
antibody),
anti-Aβ
protofibrils
(BAN2401),
AL003
(anti-CD33
antibody).
As
next
step,
taking
advantage
breakthrough
multimodal
techniques
coupled
systems
biology
approach
path
pursue
developing
individualized
strategies
targeting
framework
precision
medicine.
Journal of Neuroinflammation,
Год журнала:
2021,
Номер
18(1)
Опубликована: Янв. 5, 2021
Abstract
Background
Traumatic
brain
injury
(TBI)
is
a
leading
cause
of
death
and
disability
worldwide.
Microglial/macrophage
activation
neuroinflammation
are
key
cellular
events
following
TBI,
but
the
regulatory
functional
mechanisms
still
not
well
understood.
Myeloid-epithelial-reproductive
tyrosine
kinase
(Mer),
member
Tyro-Axl-Mer
(TAM)
family
receptor
kinases,
regulates
multiple
features
microglial/macrophage
physiology.
However,
its
function
in
regulating
innate
immune
response
M1/M2
polarization
TBI
has
been
addressed.
The
present
study
aimed
to
evaluate
role
Mer
TBI.
Methods
controlled
cortical
impact
(CCI)
mouse
model
was
employed.
siRNA
intracerebroventricularly
administered,
recombinant
protein
S
(PS)
intravenously
applied
for
intervention.
neurobehavioral
assessments,
RT-PCR,
Western
blot,
magnetic-activated
cell
sorting,
immunohistochemistry
confocal
microscopy
analysis,
Nissl
Fluoro-Jade
B
staining,
water
content
measurement,
contusion
volume
assessment
were
performed.
Results
upregulated
acute
stage
Mechanistically,
activates
signal
transducer
activator
transcription
1
(STAT1)/suppressor
cytokine
signaling
1/3
(SOCS1/3)
pathway.
Inhibition
markedly
decreases
M2-like
while
increases
M1-like
polarization,
which
exacerbates
secondary
damage
sensorimotor
deficits
after
Recombinant
PS
exerts
beneficial
effects
mice
through
activation.
Conclusions
an
important
regulator
neuroinflammation,
may
be
considered
as
potential
target
therapeutic
intervention
Science,
Год журнала:
2022,
Номер
377(6601), С. 56 - 62
Опубликована: Июнь 30, 2022
The
human
cerebral
cortex
has
tremendous
cellular
diversity.
How
different
cell
types
are
organized
in
the
and
how
organization
varies
across
species
remain
unclear.
In
this
study,
we
performed
spatially
resolved
single-cell
profiling
of
4000
genes
using
multiplexed
error-robust
fluorescence
situ
hybridization
(MERFISH),
identified
more
than
100
transcriptionally
distinct
populations,
generated
a
molecularly
defined
atlas
middle
superior
temporal
gyrus.
We
further
explored
cell-cell
interactions
arising
from
soma
contact
or
proximity
type–specific
manner.
Comparison
mouse
cortices
showed
conservation
laminar
cells
differences
somatic
species.
Our
data
revealed
human-specific
patterns
markedly
increased
enrichment
for
between
neurons
non-neuronal
cortex.
Cells,
Год журнала:
2022,
Номер
11(13), С. 2091 - 2091
Опубликована: Июнь 30, 2022
Neuroinflammation
is
a
hallmark
of
many
neurodegenerative
diseases
(NDs)
and
plays
fundamental
role
in
mediating
the
onset
progression
disease.
Microglia,
which
function
as
first-line
immune
guardians
central
nervous
system
(CNS),
are
drivers
neuroinflammation.
Numerous
human
postmortem
studies
vivo
imaging
analyses
have
shown
chronically
activated
microglia
patients
with
various
acute
chronic
neuropathological
diseases.
While
microglial
activation
common
feature
NDs,
exact
pathological
states
complex
often
contradictory.
However,
there
consensus
that
play
biphasic
conditions,
detrimental
protective
phenotypes,
overall
response
different
phenotypes
depends
on
nature
duration
inflammatory
insult,
well
stage
disease
development.
This
review
provides
comprehensive
overview
current
research
responses
health,
aging,
special
emphasis
heterogeneous
phenotypic
such
hemorrhagic
stroke
(HS),
Alzheimer's
(AD),
Parkinson's
(PD).
The
primary
focus
translational
preclinical
animal
models
bulk/single-cell
transcriptome
samples.
Additionally,
this
covers
key
receptors
signaling
pathways
potential
therapeutic
targets
to
regulate
during
aging
NDs.
age-,
sex-,
species-specific
differences
will
be
briefly
reviewed.